Breadcrumb

CTB News

Three RI-MUHC teams receive funding from the CFI and Government of Quebec

Funding will “provide our researchers with the foundational infrastructure needed to become leading-edge contributors in diverse research fields,” says Martha Crago

A second case of HIV remission

RI-MUHC researchers consulted on implications for HIV research

International team of scientists detect cause of rare pediatric brain disorder

RI-MUHC pediatric researcher joins efforts with scientists from the Rady Children’s Institute for Genomic Medicine to discover new mutation

Viral communications hacking boosts Leishmania infections

New study sheds light on viral biology, could lead to efficient vaccines against a tropical disease

Shared genetic marker offers new promise in targeting specific ovarian and lung cancers

Two new papers offer promise that a drug currently used to treat estrogen positive breast cancer may be effective in treating two different types of cancer

A hide-out for viruses in the testicles

RI-MUHC team leads an innovative study using testicular tissue to unlock the secrets of the immune system...

Quebec researchers among recipients of $34 million “Grand Challenge” Grant from Cancer Research UK to combat cancer

Research teams from McGill and MUHC are part of an international effort to uncover how chronic inflammation causes cancer

Confronting a killer

Defeating tuberculosis (TB) will require in-depth collaboration, including researchers, medical professionals but also the communities...

Heart & Stroke honours RI-MUHC researcher

On November 14, the Heart and Stroke Foundation honoured three researchers – including two McGill faculty members – with an award...

Innovative biosensor technology reveals secrets of how drugs work

What if we could take advantage of a drug’s benefit without side effects? Stéphane Laporte, PhD is conducting research in his laboratory at the Glen...

Explore news and events at the RI-MUHC